MedTrace Logo

The Effects of Inhalational Anaesthetics in Cognitive Functions in Down Syndrome Patients

NCT02971254 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2020-06-09

No results posted yet for this study

Summary

Recovery of the cognitive functions and recovery features after general anaesthesia in Down syndrome patients. A comparison of Sevoflurane and Desflurane.

Conditions

  • Down Syndrome

Interventions

DRUG

Sevoflurane

DRUG

Desflurane

Sponsors & Collaborators

  • Asklepieion Voulas General Hospital

    lead OTHER_GOV

Principal Investigators

  • Emmanouil Gkliatis, MD · GH Asklepieio Voulas

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-01
Primary Completion
2019-01-06
Completion
2019-05-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02971254 on ClinicalTrials.gov